このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use

2026年11月4日 更新者:Emily Grekin、Wayne State University

Enhancing Brief Motivational Interventions for Alcohol Use With Self-Determination Theory: A Pilot Letter-Writing Add-On

The goal of this pilot clinical trial is to learn whether adding a brief letter-writing exercise, grounded in Self-Determination Theory (SDT), to a brief motivational intervention (BMI) for alcohol use is feasible and acceptable, and to obtain preliminary estimates of its effects on psychological needs and motivation among adults who drink heavily and sometimes think about or wish they could cut back on their drinking.

The main questions it aims to answer are: (1) Is it feasible to integrate the letter-writing task into an SDT-informed BMI (recruitment, session completion, letter completion, retention)? (2) Do participants rate the letter-writing task as acceptable, appropriate, and feasible? (3) Compared with a neutral writing task, is the letter-writing task associated with higher perceived autonomy, competence, and relatedness, perceived competence for reducing drinking, and autonomous motivation?

Researchers will compare a BMI plus a neutral writing task with the same BMI plus the letter-writing task. Participants will complete a brief online screening survey; take part in a single 45-60-minute Zoom session that includes questionnaires, a 25-30-minute motivational interview, random assignment to either write an advice letter to another participant who has also thought about reducing their drinking or copy a neutral paragraph, and post-session questionnaires; and complete a 10-15-minute online follow-up survey about motivation, perceived competence, and alcohol use approximately one month later.

調査の概要

研究の種類

介入

入学 (推定)

86

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Michigan
      • Detroit、Michigan、アメリカ、48202
        • Wayne State University
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age 18 years or older
  • Resides in the United States
  • Meets the National Institute on Alcohol Abuse and Alcoholism heavy-drinking criteria in the past month
  • Answers Yes to "Do you sometimes think about reducing or wish you could reduce your alcohol use?"
  • Has internet access and a device capable of video conferencing via Zoom

Exclusion Criteria:

  • Failure to meet the inclusion criteria

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:BMI + Letter-Writing Condition

Participants will receive a brief, one-on-one, motivational intervention delivered via Zoom by a doctoral student in clinical psychology.

Immediately after the brief motivational intervention, participants write a brief advice letter to another study participant who has also thought about reducing their drinking but sometimes struggles with motivation. Prompts target autonomy, competence, and relatedness.

アクティブコンパレータ:BMI + Neutral Writing Condition

Participants will receive a brief, one-on-one, motivational intervention delivered via Zoom by a doctoral student in clinical psychology.

Immediately after the brief motivational intervention, participants copy a technical paragraph on office supply inventory management that matches the letter-writing task in length and duration.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Recruitment Feasibility: Enrollment Rate Among Eligible Individuals Who Accept an Invitation
時間枠:From accepting the invitation to the Zoom session (up to 21 days)

Percentage of eligible people who accept an invitation and then enroll (attend the Zoom session, consent, and begin the baseline survey).

From accepting the invitation to the Zoom session (up to 21 days)
Session Completion Rate
時間枠:Day 1

Percentage of enrolled participants who complete all parts of the Zoom session.

Day 1
Letter Completion Rate
時間枠:Day 1

Percentage of participants assigned to letter writing who complete a letter during the session.

Day 1
Acceptability of the Letter-Writing Task (Acceptability of Intervention Measure)
時間枠:Day 1

Mean of 4 Acceptability of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater acceptability. Letter-writing participants only.

Day 1
Appropriateness of the Letter-Writing Task (Intervention Appropriateness Measure)
時間枠:Day 1

Mean of 4 Intervention Appropriateness Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater appropriateness. Letter-writing participants only.

Day 1
Feasibility of the Letter-Writing Task (Feasibility of Intervention Measure)
時間枠:Day 1

Mean of 4 Feasibility of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater feasibility. Letter-writing participants only.

Day 1

二次結果の測定

結果測定
メジャーの説明
時間枠
Retention at One-Month Follow-Up
時間枠:Days 30 to 44 after the Zoom session

Proportion of randomized participants who complete the one-month follow-up survey within the 14-day response window (days 30-44 after the session), overall and by arm.

Days 30 to 44 after the Zoom session
State Autonomy for Drinking Decisions
時間枠:Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Single item rated 1 (not at all) to 7 (completely); higher scores mean greater autonomy.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
State Competence for Reducing Drinking
時間枠:Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Single item rated 1 (not capable at all) to 7 (extremely capable); higher scores mean greater competence.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
State Relatedness
時間枠:Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Single item rated 1 (not at all connected) to 7 (extremely connected); higher scores mean greater relatedness.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
Perceived Competence for Reducing Alcohol Use (Perceived Competence Scale)
時間枠:Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

Mean of 4 items rated 1 (not at all true) to 7 (very true); higher scores mean greater perceived competence.

Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session
Autonomous Motivation to Reduce Alcohol Use (Treatment Self-Regulation Questionnaire)
時間枠:Start of the Zoom session (baseline) and 1 month after the Zoom session

Autonomous motivation score (mean of items rated 1 to 7); higher scores mean more autonomous motivation.

Start of the Zoom session (baseline) and 1 month after the Zoom session

その他の成果指標

結果測定
メジャーの説明
時間枠
Heavy Drinking Days (Timeline Followback)
時間枠:Start of the Zoom session (baseline) and 1 month after the Zoom session

Number of days in the past 30 with 5 or more (men) or 4 or more (women) standard drinks, measured with the Timeline Followback.

Start of the Zoom session (baseline) and 1 month after the Zoom session

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月1日

一次修了 (推定)

2027年3月30日

研究の完了 (推定)

2027年4月30日

試験登録日

最初に提出

2026年10月31日

QC基準を満たした最初の提出物

2026年11月4日

最初の投稿 (実際)

2026年11月9日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月9日

QC基準を満たした最後の更新が送信されました

2026年11月4日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • IRB-25-12-8326

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する